In line with the idea that LRP2 might be a potential novel biomarker in certain cancer types, a recent effort to identify genes related to metastasis in premenopausal patients with hormone receptor positive early breast cancer identified low LRP2 expression as the top independent factor in the Breast Cancer 360 TM panel [76]. The gene discussed is LRP2; the disease is cancer.